Microbiome therapy shows promise for preventing deadly bloodstream infections in early trial
Reported byMedicalXpress ↗·Sourced by Goodlede
Researchers at City of Hope have pioneered a therapy that delivers 16 carefully selected beneficial bacteria to restore the microbiome and prevent dangerous bloodstream infections in patients receiving donor stem cell transplants for blood cancers.
This is an early trial. The therapy has not yet been tested in larger populations or approved for routine use.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at MedicalXpress
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede
Health
Health Canada approves first functional cure for some chronic hepatitis B patients
CBC Health · Verified
Animals
Belize secures final link in critical wildlife corridor connecting Mesoamerica's largest forest block
Re:wild · Verified
Animals
Grad student finds New Mexico's first Canada lynx in 25 years
Popular Science · Verified